Double-Blind, Placebo-Controlled Study to Investigate an Immunomodulatory Therapy (CYT003-QbG10) in Adult Patients With Perennial Allergic Rhinoconjunctivitis.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 01 Dec 2012

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

13 Jan 2009 Results from a subgroup analysis of patients with allergic asthma (52 out of 80 patients) have been reported in a Cytos Biotechnology media release; data from allergy diary entries were also reported.
13 Jan 2009 Results have been presented at the 2008 meeting of American College of Allergy, Asthma and Immunology according to a Cytos Biotechnology media release.
10 Jul 2008 Status changed from in progress to completed, based on results data reported in a Cytos media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com